Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Optimizing AAV manufacturing: a scalable harvest protocol
As demand for recombinant AAV (rAAV) vectors continues to rise, scalable and efficient manufacturing processes are essential for advancing gene therapy. Our latest White Paper evaluates a scalable harvest protocol across multiple AAV serotypes, comparing its impact on vector integrity, functionality, and yield against standard methods.
Key insights include:
- Vector integrity & functionality assessment
- Capsid recovery and yield efficiency
- Empty/full capsid ratios and aggregation analysis
While initial yields were slightly lower, the study confirmed that vector quality remains uncompromised, making this a promising step toward cost-effective, large-scale AAV production.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Optimizing AAV manufacturing: a scalable harvest protocol